KR20220055431A - Composition for anti-wrinkle or moisturizing containing Turbo cornutus Lightfoot and Nordotis discus discus derived peptide - Google Patents
Composition for anti-wrinkle or moisturizing containing Turbo cornutus Lightfoot and Nordotis discus discus derived peptide Download PDFInfo
- Publication number
- KR20220055431A KR20220055431A KR1020210142547A KR20210142547A KR20220055431A KR 20220055431 A KR20220055431 A KR 20220055431A KR 1020210142547 A KR1020210142547 A KR 1020210142547A KR 20210142547 A KR20210142547 A KR 20210142547A KR 20220055431 A KR20220055431 A KR 20220055431A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- abalone
- weight
- parts
- moisturizing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 54
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 24
- 241000894434 Turbo cornutus Species 0.000 title claims abstract description 8
- 241001489139 Haliotis discus Species 0.000 title claims abstract description 7
- 241000950638 Symphysodon discus Species 0.000 title claims description 5
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 title claims description 5
- 230000001153 anti-wrinkle effect Effects 0.000 title 1
- 230000036541 health Effects 0.000 claims abstract description 36
- 239000002537 cosmetic Substances 0.000 claims abstract description 33
- 230000037303 wrinkles Effects 0.000 claims abstract description 32
- 235000013376 functional food Nutrition 0.000 claims abstract description 29
- 235000013402 health food Nutrition 0.000 claims abstract description 25
- 230000003796 beauty Effects 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 239000008213 purified water Substances 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 102000035195 Peptidases Human genes 0.000 claims description 16
- 108091005804 Peptidases Proteins 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 230000006872 improvement Effects 0.000 claims description 14
- 235000013372 meat Nutrition 0.000 claims description 14
- 235000015278 beef Nutrition 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 239000006210 lotion Substances 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 108090001109 Thermolysin Proteins 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 235000015110 jellies Nutrition 0.000 claims description 5
- 239000008274 jelly Substances 0.000 claims description 5
- 235000019833 protease Nutrition 0.000 claims description 5
- 235000019419 proteases Nutrition 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 108010006035 Metalloproteases Proteins 0.000 claims description 4
- 102000005741 Metalloproteases Human genes 0.000 claims description 4
- 241000036848 Porzana carolina Species 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 210000000936 intestine Anatomy 0.000 claims description 4
- -1 pack Substances 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims 1
- 239000008269 hand cream Substances 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 37
- 239000013543 active substance Substances 0.000 description 20
- 239000000523 sample Substances 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000013355 food flavoring agent Nutrition 0.000 description 9
- 102000016387 Pancreatic elastase Human genes 0.000 description 8
- 108010067372 Pancreatic elastase Proteins 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241000193389 Bacillus thermoproteolyticus Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000021191 food habits Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 소라(Turbo cornutus Lightfoot) 및 전복(Nordotis discus discus) 유래의 펩타이드를 포함하는 주름개선 또는 보습용 조성물에 관한 것으로, 상기 조성물은 화장료 또는 이너뷰티 형태의 건강식품 또는 건강기능식품으로 유용할 수 있다.The present invention relates to a composition for wrinkle improvement or moisturizing comprising a peptide derived from conch ( Turbo cornutus Lightfoot ) and abalone ( Nordotis discus discus ), and the composition may be useful as a cosmetic or inner beauty health food or health functional food. can
피부는 외부 환경으로부터 몸을 보호하여 체내 항상성을 유지하는데 중요한 역할을 한다. 그러나 끊임없는 외부의 여러 자극과 자체 대사과정 등에서 생기는 불필요한 대사산물(metabolite)에 의해 피부 기능은 저하되고 노화 현상이 촉진된다. 주름생성에 대한 원인으로 여러 가지가 보고되고 있는데, 우선 피부가 과다한 자외선에 노출되면 피부 구성성분인 콜라겐(collahen)분해가 촉진되어 피부가 탄력을 읽고 주름이 생성될 수 있다. 피부 내 콜라겐은 피부 섬유아세포에서 생성되는 구조 단백질로 노화에 의한 생성 감소 및 해당 구조의 변화는 피부의 주름 형성과 관련이 있다고 알려져 있다. 그러므로 피부 내 콜라겐 생성, 각질 줄기세포 생장에 관련된 체내 항상성은 피부의 건강 및 미용에 영향을 주는 밀접한 인자로써 이에 대한 기능과 유효 소재 발굴을 위한 연구는 여전히 활발히 진행되고 있으나, 표면에 도포하는 외용적 처치 소재의 유효성은 표피 및 진피를 통과해야 하는 기술적 어려움으로 인해 많은 노력이 요구된다.The skin plays an important role in maintaining homeostasis in the body by protecting the body from the external environment. However, the skin function is deteriorated and the aging phenomenon is accelerated by the constant external stimuli and unnecessary metabolites generated in its own metabolic processes. Various causes of wrinkles have been reported. First, when the skin is exposed to excessive UV rays, the decomposition of collagen, which is a component of the skin, is promoted, so that the skin reads elasticity and wrinkles are formed. Collagen in the skin is a structural protein produced by fibroblasts in the skin, and it is known that a decrease in the production due to aging and a change in the corresponding structure are related to the formation of wrinkles in the skin. Therefore, in vivo homeostasis related to collagen production and keratinocyte growth in the skin is a close factor that affects the health and beauty of the skin. The effectiveness of the treatment material requires a lot of effort due to the technical difficulties of passing through the epidermis and dermis.
사람의 생체는 생명체 유지에 중요한 역할을 하는 물로 대부분 구성되어 있다. 정상 피부에서의 수분은 체내에 70%, 각질층에 20%가 함유되어 있어 피부의 탄력성 및 유연성을 지탱해 준다. 각질층의 수분이 10% 이하일 경우, 피부는 건성화되고 피부 트러블의 원인이 된다고 알려져 있다. 피부의 수분균형은 표피(epidermis)에 의해 조절된다. 표피의 각질층은 죽은 세포들이 쌓여 있는 것이지만 피부의 수분 유지를 위해서 매우 중요한 역할을 한다. 규칙적인 각질화(keratinization)로 생성된 각질층 안의 수분의 양은 항상 10~20%를 유지한다. 이것은 땀과 피지의 혼합으로 되어있는 피지막 때문으로, 외부로부터 피부를 보호하고, 각질층에서 수분이 증발되는 것을 막고 있다. 천연보습인자(Natural Moisturizing Factor; 이하 NMF)와 진피지질은 수분을 잡고 있으며 또 유지시켜준다. 피지막(sebaceous membrane), NMF 및 진피지질은 피부의 수분을 유지하는데 같이 작용하고 있다. NMF는 각질화 과정에서 생성되는 것으로 친수성의 흡습성 물질로 피부 보습에 있어서 중요한 역할을 맡고 있다. 이것은 아미노산(amino acid)으로 만들어졌으며 각질층(horny layer)의 수분을 잡고 있다. 또한 NMF 중에서 2-피롤리딘-5-카르복시산(2-pyrrolidine-5-carboxylic acid, PCA)은 특히 중요하다. 각각의 세포들 사이에 채워져 있는 기질로 층을 형성하고 안쪽의 수분을 유지하고 있다(피부장벽학회지, 4, 71-80, 2002).The human body is mostly composed of water, which plays an important role in maintaining life. As normal skin contains 70% of moisture in the body and 20% in the stratum corneum, it supports the elasticity and flexibility of the skin. It is known that when the moisture in the stratum corneum is 10% or less, the skin becomes dry and causes skin troubles. The moisture balance of the skin is regulated by the epidermis. Although the stratum corneum of the epidermis is a pile of dead cells, it plays a very important role in maintaining moisture in the skin. The amount of water in the stratum corneum produced by regular keratinization is always maintained at 10-20%. This is because of the sebum film, which is a mixture of sweat and sebum, protecting the skin from the outside and preventing moisture from evaporating from the stratum corneum. Natural Moisturizing Factor (NMF) and dermal lipids hold and maintain moisture. The sebaceous membrane, NMF and dermal lipids work together to retain moisture in the skin. NMF is a hydrophilic, hygroscopic substance that is generated during the keratinization process and plays an important role in moisturizing the skin. It is made of amino acids and holds moisture in the horny layer. In addition, 2-pyrrolidine-5-carboxylic acid (PCA) in NMF is particularly important. It forms a layer with the matrix filled between each cell and maintains moisture inside (Journal of the Skin Barrier Society, 4, 71-80, 2002).
소라(Batillus cornutus)는 연체동물 소라과에 속하는 종으로, 일본, 중국, 우리나라등에 주로 분포를 하며, 조간대 암반지역에 서식하다가 성장을 하면서 수심 20m 내외의 암초지역에 분포 한다. 소라는 파도 등 해류의 영향에 따라 무뿔소라와 뿔소라 형태로 나타나며, 남해안과 울릉도까지 분포를 하지만 대부분 제주도 주변에 분포를 한다. 소라는 깊은곳에서 각고 12cm 이상 개체도 발견되지만 대체적으로 6-10cm급에서 주요 산란급으로 이루어지며 피채는 간조시 노출되는 조간대에서 서식하며 점차 성장하면서 깊은곳으로 이동한다. 제주도산 소라(Turbo cornutus Solander)는 식용으로 가치가 높으며 1970년대 이후 주요 수출품목으로 자리 메김 함으로써 해녀에 있어서는 최고의 소득품종으로 알려져 있다. 칼슘, 철분, 인 등의 미네랄과 비타민 A를 함유하고 있는 고단백 식품으로서 알려진 소라를 이미용 원료로 사용하기 위하여 연구를 진행하였다. Conch (Batillus cornutus) is a species belonging to the mollusk family Hermitaceae, and is mainly distributed in Japan, China, and Korea. It inhabits and grows in intertidal bedrock areas and is distributed in reef areas with a depth of about 20m. Conch appears in the form of rhinoceros and horned conch depending on the influence of currents such as waves, and is distributed to the southern coast and Ulleungdo, but is mostly distributed around Jeju Island. Conch is also found in the depths of 12cm or taller, but it is generally found in the 6-10cm class and the main spawning class. Turbo cornutus Solander from Jeju Island is highly edible and has been established as a major export item since the 1970s, and is known as the best income breed for haenyeo. A study was conducted to use conch, known as a high-protein food containing minerals such as calcium, iron, phosphorus, and vitamin A, as a cosmetic raw material.
건조된 소라(원물)에 배양된 균을 직접 접종하는 방법을 사용하였을 때 발효에 사용되는 미생물은 최종 화장료 조성물에서 배양되어 악영향을 끼칠 수 있으며, 잔류된 배양액 성분이 혼합되어, 의도치 않은 영향을 미칠 수 있다는 단점을 가지고 있다.When the method of directly inoculating dried conch (original material) with cultured bacteria is used, microorganisms used for fermentation are cultured in the final cosmetic composition and may adversely affect, and the remaining culture medium components are mixed, causing an unintended effect. It has the disadvantage that it can go crazy.
최근 뷰티시장이 다양화되고 있으며, 다기능의 화장품 출시와 더불어 내면적인 아름다움을 추구하는 이너뷰티 트렌드가 점차 확산되면서 미래의 성장뷰티 시장을 예고하는 이른바 먹는 화장품, 이너뷰티 브랜드 시대가 열리고 있다.Recently, the beauty market is diversifying, and the inner beauty trend that pursues inner beauty is gradually spreading along with the launch of multifunctional cosmetics.
이너뷰티는 내면의(inner) 아름다움(beauty)을 뜻하며, 화장품을 바르는 등 인위적인 방법으로 피부 표면만을 일시적으로 좋게 만드는 것이 아니라, '식습관'과 '생활습관'을 통해 피부 속 건강을 챙겨 피부 자체를 좋게 한다는 의미로, 아름답기를 소망하는 사람들의 욕망이 커지면서 먹는 화장품이라 불리는 이너뷰티에 대한 관심이 증가하고 있는 실정이다.Inner beauty means inner beauty, and it does not temporarily improve the skin surface by artificial methods such as applying cosmetics, but takes care of the health of the skin through 'food habits' and 'lifestyle' to take care of the skin itself. In the sense of good, as the desire of people who wish to be beautiful is growing, interest in inner beauty, which is called edible cosmetics, is increasing.
섭취 가능한 화장품은 인체 피부에 직접 도포하는 화장품에 비해 주름개선, 미백효과와 같은 기능성이 미흡하다는 문제점과 함께 피부 질환을 완화 또는 개선토록 하는 유효성분이 단일물질로만 이루어져, 예컨대 다양한 루트를 통해 발생되는 피부 관련 질환의 원인인자를 표적하지 못하여 효율적인 피부 관리를 할 수 없다는 문제점 또한 내포하고 있다.Ingestible cosmetics have problems such as wrinkle improvement and whitening effect are insufficient compared to cosmetics applied directly to the human skin, and the active ingredient that alleviates or improves skin diseases is made of only a single substance, for example, skin generated through various routes. It also contains the problem that effective skin care cannot be performed because it cannot target the causative factors of related diseases.
이러한 단점을 극복하기 위해 미생물에서 추출된 효소를 이용하여 고분자의 펩타이드를 저분자화 시키는 가수분해를 하기 위한 방법을 발굴하여 피부의 주름개선 또는 보습에 효과적인 다기능성 펩타이드 소재를 발굴하여, 본 발명을 완성하였다.In order to overcome this disadvantage, we discovered a method for hydrolyzing high molecular weight peptides using enzymes extracted from microorganisms, and discovered a multifunctional peptide material that is effective for improving wrinkles or moisturizing the skin, thereby completing the present invention. did
본 발명의 목적은 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 피부의 주름개선 또는 보습용 화장료 조성물을 제공하는 것이다.It is an object of the present invention to provide a cosmetic composition for improving skin wrinkles or moisturizing the skin comprising a conch-derived peptide and an abalone-derived peptide.
본 발명의 다른 목적은 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 피부 주름 예방 또는 개선용 건강식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a health food composition for preventing or improving skin wrinkle comprising a conch-derived peptide and an abalone-derived peptide.
본 발명의 또 다른 목적은 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 피부 주름 예방 또는 개선용 건강기능식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a health functional food composition for preventing or improving skin wrinkles, comprising a conch-derived peptide and an abalone-derived peptide.
상기 목적을 달성하기 위하여, In order to achieve the above object,
본 발명은 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 피부의 주름개선 또는 보습용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for wrinkle improvement or moisturizing of skin comprising a conch-derived peptide and an abalone-derived peptide.
바람직하게, 상기 소라는 제주산 소라(Turbo cornutus Lightfoot)를 사용할 수 있고, 상기 전복은 제주산 전복(Nordotis discus discus)을 사용할 수 있다.Preferably, the conch is Jeju conch ( Turbo ). cornutus Lightfoot ) may be used, and the abalone from Jeju may be used ( Nordotis discus discus ).
소라 유래 펩타이드 제조방법Method for producing a conch-derived peptide
상기 소라 유래 펩타이드는,The sora-derived peptide is
소라육을 40-80℃에서 12-72시간 건조하는 단계(단계 1);drying the beef meat at 40-80° C. for 12-72 hours (step 1);
상기 단계 1의 건조된 소라육을 20-100 mesh로 분쇄하는 단계(단계 2);pulverizing the dried beef meat of step 1 to 20-100 mesh (step 2);
상기 단계 2의 소라육 100 중량부에 정제수를 800-1000 중량부로 혼합 후, 1.4-1.6 atm, 100-120℃에서 30-40분간 자숙하는 단계(단계 3);After mixing 800-1000 parts by weight of purified water with 100 parts by weight of the beef meat of step 2, self-restraint at 1.4-1.6 atm, 100-120° C. for 30-40 minutes (step 3);
상기 단계 3의 소라육 자숙물 1000 중량부에 가수분해원을 1-10 중량부로 혼합하여 3-24시간 동안, 25-50℃에서 발효 후, 80-90℃에서 10-20분간 효소를 비활성화 하는 단계 (단계 4); 및1-10 parts by weight of a hydrolysis source is mixed with 1000 parts by weight of the boiled beef broth of step 3, fermented at 25-50°C for 3-24 hours, and then the enzyme is inactivated at 80-90°C for 10-20 minutes. step (step 4); and
상기 단계 4의 발효 후 2,000-6,000rpm으로 원심분리한 후 농축 및 동결건조하여 분말로 제조하는 단계(단계 5);After the fermentation of step 4, centrifugation at 2,000-6,000 rpm, concentration and freeze-drying to prepare a powder (step 5);
를 포함하여 제조할 수 있다.It can be prepared including
상기 소라 유래 펩타이드 제조방법에 있어서, 상기 단계 1은 소라를 40-80℃에서 12-72시간 건조하는 단계이다. 바람직하게는 60℃에서 24시간 건조할 수 있다. In the method for producing a conch-derived peptide, step 1 is a step of drying conch at 40-80° C. for 12-72 hours. Preferably, it may be dried at 60° C. for 24 hours.
상기 소라 유래 펩타이드 제조방법에 있어서, 상기 단계 2는 상기 단계 1의 건조된 소라를 20-100 mesh로 분쇄하는 단계이다.In the method for producing a conch-derived peptide, step 2 is a step of pulverizing the dried conch of step 1 to 20-100 mesh.
상기 소라 유래 펩타이드 제조방법에 있어서, 상기 단계 3은 상기 단계 2의 소라 100중량부에 정제수를 800-1000 중량부로 혼합 후 100-120℃ 에서 30-40분간 자숙하는 단계이다. 바람직하게 자숙온도는 104-116℃에서 자숙시간은 31-39분간 자숙할 수 있고, 더욱 바람직하게는 105-115℃에서 32-38분간 자숙할 수 있다. 자숙온도가 100℃ 미만이거나 120℃를 초과할 경우 정제수에 용해되는 단백질의 함량이 낮아지고, 또한 자숙시간이 30분 미만이거나 40분을 초과할 경우 정제수에 용해되는 단백질의 함량이 낮아지는 문제가 있을 수 있다. 본 발명에 따른 자숙 조건에서 소라 유래 단백질이 정제수에 높은 비율로 용해될 수 있으며, 단백질이 용해될수록 이후 발효(가수분해)단계에서 전체 단백질 함량 대비하여 생성되는 펩타이드의 함량이 높아지는 효과가 있다. In the method for producing a conch-derived peptide, step 3 is a step of mixing 800-1000 parts by weight of purified water with 100 parts by weight of the conch of step 2, followed by self-remediation at 100-120° C. for 30-40 minutes. Preferably, the self-sustaining temperature may be 104-116° C., and the self-sustaining time may be 31-39 minutes, and more preferably, self-reflection may be performed at 105-115° C. for 32-38 minutes. When the self-sustaining temperature is less than 100 °C or exceeds 120 °C, the content of protein soluble in purified water is lowered there may be Conch-derived protein can be dissolved in purified water at a high rate under the self-sustaining conditions according to the present invention, and the more the protein is dissolved, the higher the content of the peptide produced compared to the total protein content in the subsequent fermentation (hydrolysis) step.
상기 소라 유래 펩타이드 제조방법에 있어서, 상기 단계 4는 소라 자숙물 1000 중량부에 가수분해원을 1-10 중량부로 혼합하여 3-24시간 동안, 25-45℃에서 발효 후 50-80℃에서 10-20분간 효소를 비활성화하는 단계이다. 상기 가수분해원은 바람직하게 소라 자숙물 1000 중량부에 가수분해원 5 중량부로 혼합할 수 있으며, 가수분해원은 프로테아제(protease) 또는 펩티다아제(peptidase)를 포함하는 미생물 또는 단백질 가수분해 효소인 것을 특징으로 하며, 바람직하게는 프로테아제(protease) 또는 펩티다아제(peptidase)를 포함하는 미생물은 바실러스 서브틸러스(bacillus subtilis) 등을 사용할 수 있다. 또한, 상기 단백질 가수분해 효소는 메탈로펩티다아제, 메탈로프로테아제 등을 단독으로 또는 혼합하여 사용할 수 있으며, 더욱 바람직하게는 썰모라이신(Thermolysin: EC 3.4.24.27. Bacillus thermoproteolyticus가 생산하는 미생물유래 단백질 분해효소)을 사용할 수 있다. 또한, 상기 비활성화 하는 단계는 바람직하게 80℃에서 15분간 효소를 비활성화 할 수 있다. In the method for producing a conch-derived peptide, step 4 is performed by mixing 1-10 parts by weight of a hydrolysis source with 1000 parts by weight of conch fermented water, fermenting at 25-45°C for 3-24 hours, and then at 50-80°C for 10 - This is the step of inactivating the enzyme for 20 minutes. The hydrolysis source may be preferably mixed with 5 parts by weight of the hydrolysis source in 1000 parts by weight of the conch shellfish, and the hydrolysis source is a microorganism or proteolytic enzyme containing protease or peptidase. and preferably, a microorganism containing a protease or a peptidase may be Bacillus subtilis or the like. In addition, the proteolytic enzyme may be used alone or in combination with metallopeptidase, metalloprotease, etc., and more preferably, thermolysin (EC 3.4.24.27. Bacillus thermoproteolyticus). enzymes) can be used. In addition, the inactivating step may preferably inactivate the enzyme at 80 ℃ for 15 minutes.
상기 소라 유래 펩타이드 제조방법에 있어서, 상기 단계 5는 상기 단계 4의 발효 후 2,000-6,000rpm으로 원심분리한 후 농축 및 동결건조하여 분말로 제조하는 단계이다. 바람직하게는 상기 단계 4의 발효 후 3,000rpm으로 원심분리할 수 있다.In the method for producing a conch-derived peptide, step 5 is a step of preparing a powder by centrifugation at 2,000-6,000 rpm after fermentation in step 4, concentration and freeze-drying. Preferably, it may be centrifuged at 3,000 rpm after the fermentation of step 4.
전복 유래 펩타이드 제조방법Abalone-derived peptide manufacturing method
상기 전복 유래 펩타이드는,The abalone-derived peptide is
전복의 패각 및 내장을 제거한 후, 전복육을 40-80℃에서 12-72시간 건조하는 단계(단계 1);After removing the shell and intestines of abalone, drying the abalone meat at 40-80° C. for 12-72 hours (step 1);
상기 단계 1의 건조된 전복육을 20-100 mesh로 분쇄하는 단계(단계 2);pulverizing the dried abalone meat of step 1 to 20-100 mesh (step 2);
상기 단계 2의 전복육 분말 100 중량부에 정제수 800-1000 중량부를 혼합 후, 1.4-1.6 atm, 100-120℃에서 30-40분간 자숙하는 단계(단계 3);After mixing 800-1000 parts by weight of purified water with 100 parts by weight of the abalone meat powder of step 2, self-restraint at 1.4-1.6 atm, 100-120° C. for 30-40 minutes (step 3);
상기 단계 3에서 정제수를 버리고 남은 자숙 전복육 100 중량부 기준 1N 농도의 수산화나트륨 800-1000 중량부를 첨가한 후 70-90℃에서 3-5시간 동안 125-175 rpm으로 교반하여 전복육의 단백질을 추출하는 단계(단계 4);After discarding the purified water in step 3 and adding 800-1000 parts by weight of sodium hydroxide at a 1N concentration based on 100 parts by weight of the remaining raw abalone meat, the protein of the abalone meat was prepared by stirring at 125-175 rpm at 70-90° C. for 3-5 hours. extracting (step 4);
상기 단계 4에서 얻은 전복육 단백질 추출물을 교반하며 아세트산을 첨가하여 pH 2-4로 조절한 다음, 3000-4000 rpm에서 5-15분간 원심분리하여 침전물을 얻는 단계(단계 5);The abalone protein extract obtained in step 4 is stirred and adjusted to pH 2-4 by adding acetic acid, and then centrifuged at 3000-4000 rpm for 5-15 minutes to obtain a precipitate (step 5);
상기 단계 5에서 얻은 침전물을 교반하며 1N 농도의 수산화나트륨을 첨가하여 pH 6.5-7.5까지 중화시키는 단계(단계 6); 및neutralizing the precipitate obtained in step 5 to pH 6.5-7.5 by adding 1N sodium hydroxide while stirring (step 6); and
상기 단계 6에서 얻은 중화된 침전물에 에탄올을 첨가하여 세척한 다음 에탄올을 제거하여, 전복 펩타이드를 얻는 단계(단계 7);Washing by adding ethanol to the neutralized precipitate obtained in step 6, then removing the ethanol to obtain an abalone peptide (step 7);
를 포함하여 제조할 수 있다.It can be prepared including
또한, 본 발명은 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 피부 주름 예방 또는 개선용 건강식품 조성물을 제공한다. 본 발명에 따른 건강식품의 일례로는 이너뷰티(inner beauty) 식품일 수 있고, 식품의 예로는 젤리 형태의 이너뷰티 식품일 수 있다.In addition, the present invention provides a health food composition for preventing or improving skin wrinkles, comprising a conch-derived peptide and an abalone-derived peptide. An example of the health food according to the present invention may be an inner beauty food, and an example of the food may be a jelly-type inner beauty food.
나아가, 본 발명은 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 피부 주름 예방 또는 개선용 건강기능식품 조성물을 제공한다. 본 발명에 따른 건강기능식품의 일례로는 이너뷰티(inner beauty) 식품일 수 있고, 식품의 예로는 젤리 형태의 이너뷰티 식품일 수 있다.Furthermore, the present invention provides a health functional food composition for preventing or improving skin wrinkles, comprising a conch-derived peptide and an abalone-derived peptide. An example of the health functional food according to the present invention may be an inner beauty food, and an example of the food may be a jelly-type inner beauty food.
상기 젤리는 비타민C, 효소처리 스테비아, 엘라스틴, 정제수, 프락토올리고당, 치커리 식이섬유, 로커스트콩검, 잔탄검, 포도당, 한천, 타마린드검을 혼합하여 젤리 베이스를 준비한 다음, 본 발명에 따른 소라 유래 펩타이드 및 전복 유래 펩타이드를 혼합하여 제조할 수 있다.The jelly is prepared by mixing vitamin C, enzyme-treated stevia, elastin, purified water, fructooligosaccharide, chicory dietary fiber, locust bean gum, xanthan gum, glucose, agar, and tamarind gum to prepare a jelly base, and then, the conch-derived peptide according to the present invention. And it can be prepared by mixing abalone-derived peptides.
본 발명에 따른 소라 유래 펩타이드 및 전복 유래 펩타이드를 포함하는 조성물은 피부의 주름개선 또는 보습력이 현저히 향상되는 효과가 있다.The composition comprising the conch-derived peptide and the abalone-derived peptide according to the present invention has the effect of remarkably improving the skin's wrinkle improvement or moisturizing power.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
화장료 조성물cosmetic composition
상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition is, for example, a solution, a gel, a solid or kneaded anhydrous product, an emulsion obtained by dispersing an oil phase in an aqueous phase, a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome), a non-ionic vesicle dispersant It may be provided in the form of a cream, toner, lotion, powder, ointment, spray or concealer stick. In addition, it may be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 유효물질에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition comprises a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, Commonly used in water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or cosmetics It may contain adjuvants commonly used in the cosmetic field, such as any other ingredients that are used.
본 발명의 유효물질을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 유효물질이 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the active substance of the present invention, the active substance of the present invention may be added in an amount of 0.1 to 50% by weight, preferably 1 to 10% by weight, to the cosmetic composition usually contained.
본 발명의 유효물질을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.When the active substance of the present invention is used as an external preparation for skin, in addition, a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant , water, ionic or non-ionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or for external use on the skin It may contain adjuvants conventionally used in the field of dermatology, such as any other ingredients used as a skin care product. In addition, the above ingredients may be introduced in an amount generally used in the field of dermatology.
건강식품/건강기능식품 조성물Health food/health functional food composition
건강식품 및 건강기능식품의 종류에는 특별한 제한은 없다. 본 발명의 유효물질을 첨가할 수 있는 건강기능식품의 예로는 젤리, 드링크제, 타블렛, 캡슐, 분말, 환, 육류, 소시지, 빵, 비스킷, 떡, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 알코올 음료 및 비타민 복합제, 유제품 및 유가공 제품 등이 있으며, 통상적인 의미에서의 건강식품 및 건강기능성식품을 모두 포함한다.There are no special restrictions on the types of health food and health functional food. Examples of health functional foods to which the active substance of the present invention can be added include jelly, drinks, tablets, capsules, powders, pills, meat, sausage, bread, biscuits, rice cakes, chocolate, candies, snacks, confectionery, pizza, ramen, There are other noodles, gums, dairy products including ice cream, various soups, beverages, alcoholic beverages and vitamin complexes, dairy products, and dairy products, and includes all health food and health functional food in the ordinary sense.
본 발명에 따른 유효물질을 함유하는 건강식품 및 건강기능성식품 조성물은 식품에 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효물질의 혼합량은 그의 사용 목적(예방 또는 개선용)에 따라 적합하게 결정될 수 있다. 일반적으로, 건강식품 및 건강기능성식품 중의 상기 조성물의 양은 전체 식품 중량의 0.1 내지 90 중량부로 가할 수 있다. 그러나 건강 유지를 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.The health food and health functional food composition containing the active substance according to the present invention may be added to food as it is or used together with other food or food ingredients, and may be appropriately used according to a conventional method. The mixing amount of the active substance may be suitably determined according to the purpose of its use (for prevention or improvement). In general, the amount of the composition in health food and health functional food may be added in an amount of 0.1 to 90 parts by weight based on the total weight of the food. However, in the case of long-term intake for health maintenance or health control, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
본 발명의 건강식품 및 건강기능성식품 조성물은 지시된 비율로 필수 성분으로서 본 발명 유효물질을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트라이톨 등의 당알코올이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 건강식품 및 건강기능성식품 조성물 100 당 일반적으로 약 1 내지 20 g, 바람직하게는 약 5 내지 12 g이다.The health food and health functional food composition of the present invention is not particularly limited in other ingredients other than containing the active substance of the present invention as an essential ingredient in the indicated ratio, and various flavoring agents or natural carbohydrates are added as additional ingredients like conventional beverages. may contain. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; disaccharides such as maltose, sucrose and the like; and polysaccharides such as conventional sugars such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those described above, natural flavoring agents (taumatin, stevia extract (eg, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The proportion of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g per 100 health food and health functional food composition of the present invention.
상기 외에 본 발명의 유효물질을 함유하는 건강식품 및 건강기능성식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강식품 및 건강기능성식품 조성물은 천연 과일쥬스 및 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.In addition to the above, health food and health functional food composition containing the active substance of the present invention are various nutrients, vitamins, minerals (electrolytes), synthetic flavoring agents and flavoring agents such as natural flavoring agents, coloring agents and thickening agents (cheese, chocolate, etc.) ), pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. In addition, the health food and health functional food composition of the present invention may contain natural fruit juice, fruit juice, and fruit for the production of fruit juice drinks and vegetable drinks.
이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 유효물질을 함유하는 건강식품 및 건강기능성식품 조성물 100 중량부 당 0.1 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.These components may be used independently or in combination. The proportion of these additives is not so important, but is generally selected in the range of 0.1 to about 20 parts by weight per 100 parts by weight of the health food and health functional food composition containing the active substance of the present invention.
이하, 본 발명을 하기의 실시예에 의하여 더욱 상세하게 설명한다. 단, 하기의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples only illustrate the present invention, and the content of the present invention is not limited by the following examples.
<제조<Manufacturing 예Yes 1> 제주산 소라( 1> Jeju Conch ( TurboTurbo cornutuscornutus Lightfootlightfoot ) 유래 ) origin 펩타이드의of peptide 제조 Produce
단계 1: 제주산 소라의 패각 및 내장을 제거한 후 정제수로 1회 수세한 후 60℃에서 제주산 소라육을 24시간 건조 시킨다.Step 1: After removing the shells and intestines of the Jeju conch, wash it with purified water once, and then dry the Jeju conch meat at 60°C for 24 hours.
단계 2: 단계 1 후에 그라인더를 이용해 20~100mesh로 분쇄한다.Step 2: After step 1, grind to 20~100mesh using a grinder.
단계 3: 분쇄된 제주산 소라 분말 100g과 정제수 900ml을 혼합하여 110℃에서 35분간 밀폐된 고압(1.5atm) 고온의 용기내에서 가온하여 자숙한다.Step 3: 100 g of crushed Jeju conch powder and 900 ml of purified water are mixed and heated at 110° C. for 35 minutes in a sealed high-pressure (1.5 atm) high-temperature container to self-destruct.
단계 4: 자숙된 제주산 소라육(제주산 소라육 100g + 정제수 900ml)을 35℃까지 냉각한 후 온도를 유지하며, 썰모라이신(Thermolysin) 5g을 첨가한 후 4시간 동안 150rpm으로 교반하여 제주산 소라육의 단백질들을 가수분해하여 펩타이드화 한다. 상기 썰모라이신은 EC 3.4.24.27. Bacillus thermoproteolyticus가 생산하는 미생물유래 단백질 분해효소이다.Step 4: After cooling the cooked Jeju beef (100 g of Jeju beef + 900 ml of purified water) to 35 ° C, the temperature was maintained, 5 g of Thermolysin was added, and stirred at 150 rpm for 4 hours to Jeju. It hydrolyzes the proteins of oxygenated beef meat to make it into peptides. The thermolysin is EC 3.4.24.27. It is a microorganism-derived proteolytic enzyme produced by Bacillus thermoproteolyticus.
단계 5: 효소에 의해 가수분해(발효)가 완료된 가수분해물은 3,000rpm으로 원심분리하여 정제수에 용해되지 않는 제주산 소라육 및 이물질들을 제거한다. 회수된 상등액은 감압농축 및 동결건조를 통해 분말화 하여 제주산 소라육 펩타이드 분말을 제조하였다.Step 5: The hydrolyzate, which has been hydrolyzed (fermented) by the enzyme, is centrifuged at 3,000 rpm to remove Jeju beef meat and foreign substances that are not soluble in purified water. The recovered supernatant was powdered through concentration under reduced pressure and freeze-drying to prepare a Jeju beef ox peptide powder.
<제조예 2> 제주산 전복(<Preparation Example 2> Jeju abalone ( NordotisNordotis discusdiscus discusdiscus ) 유래 펩타이드의 제조) Preparation of Derived Peptides
단계 1: 제주산 전복의 패각 및 내장을 제거한 후 정제수로 1회 수세한 후 60℃에서 제주산 전복육을 24시간 건조 시킨다.Step 1: After removing the shells and intestines of Jeju abalone, wash it with purified water once, and then dry the Jeju abalone meat at 60°C for 24 hours.
단계 2: 단계 1 후에 그라인더를 이용해 20~100mesh로 분쇄한다.Step 2: After step 1, grind to 20~100mesh using a grinder.
단계 3: 분쇄된 제주산 전복 분말 100g과 정제수 900ml을 혼합하여 110℃에서 35분간 밀폐된 고압(1.5atm) 고온의 용기내에서 가온하여 자숙한다.Step 3: 100 g of crushed Jeju abalone powder and 900 ml of purified water are mixed and heated at 110° C. for 35 minutes in a sealed high-pressure (1.5 atm) high-temperature container to self-destruct.
단계 4: 자숙된 제주산 전복육(제주산 전복육 100g + 정제수 900ml)에서 정제수를 버리고 1N NaOH를 900ml 첨가한 후 80℃를 유지하며 4시간 동안 150rpm으로 교반하여 제주산 전복육의 단백질을 추출한다. Step 4: Discard the purified water from the cooked Jeju abalone (100g Jeju abalone + 900ml purified water), add 900ml of 1N NaOH, and then maintain 80℃ and stir at 150rpm for 4 hours to extract the protein of Jeju abalone do.
단계 5: 전복육 추출물을 교반하면서 아세트산(Acetic acid)을 첨가하여 pH 2.0 ~ 4.0으로 맞춰 준다. 원심분리기를 이용하여 3,500rpm 에서 10분간 원심분리하여 침전물을 얻는다. 산성으로 맞춰주는 것은 단백질의 등전점에서 전하를 띄지 않게 되어 이동성이 없어지고 그 지점에서 단백질을 분리하기 위함이다.Step 5: While stirring the abalone meat extract, add acetic acid to adjust the pH to 2.0 ~ 4.0. A precipitate is obtained by centrifugation at 3,500 rpm for 10 minutes using a centrifuge. Adjusting to acidity is to remove the charge at the isoelectric point of the protein, thereby losing mobility, and separating the protein at that point.
단계 6: 침전물을 교반하면서 1N NaOH를 첨가하여 pH 7이 될 때까지 중화시켜준다.Step 6: The precipitate is neutralized until pH 7 is obtained by adding 1N NaOH while stirring.
단계 7: 중화시킨 제주산 전복육 추출물 부피의 4배의 에탄올을 첨가하여 150rpm으로 천천히 교반시켜준다. 원심분리기를 이용항 3,500rpm 에서 10분간 원심분리하여 에탄올을 제거한 후 남은 에탄올은 감압농축으로 마저 제거하고 분말화 하여 제주산 전복육 펩타이드 분말을 제조하였다.Step 7: Add 4 times the volume of the neutralized Jeju abalone extract and stir slowly at 150rpm. After removing the ethanol by centrifugation using a centrifuge at 3,500 rpm for 10 minutes, the remaining ethanol was even removed by concentration under reduced pressure and powdered to prepare Jeju abalone peptide powder.
<< 실험예Experimental example 1> 주름개선 활성 평가 1> Wrinkle improvement activity evaluation
엘라스타아제 활성저해 효과를 문헌에 기재된 방법을 이용하여 하기와 같이 측정하였다(Lee et al., J. Cosmetic Science, 49, 285-297, 1998).Elastase activity inhibitory effect was measured using the method described in the literature as follows (Lee et al., J. Cosmetic Science, 49, 285-297, 1998).
구체적으로, 완충액(0.267M Tris 액을 pH 8.0이 되도록 0.267M 염산(HCl)액으로 조정하였다) 60㎕에 기질액(엘라스타아제 기질 Succ-Ala-Ala-Ala-p-nitroanilide 표준품(SIGMA, S4760)을 8.8mM로 하였다) 20㎕ 및 시료 100㎕(실시예 1 및 비교예 1-2 각각의 시료를 정제수에 100ppm 농도로 희석하여 제조)를 넣어 섞고, 효소액(10㎍/㎖, 돼지 췌장 엘라스타아제 표준품 : Porcine Pancreatic Elastase, SIGMA, E-1250) 20㎕를 넣어 흔들어 섞어 25℃에서 15분간 반응시키고, p-니트로아닐린(p-nitroaniline)의 생성량을 파장 410nm에서 흡광도 B를 측정하였다(검액). 완충액 60㎕에 기질액 20㎕, 정제수 20㎕ 및 시료 100㎕를 넣어 위와 같은 방법으로 조작하여 얻은 액을 대조액으로 하여 흡광도 C를 측정하였다. 또한, 시료 대신 정제수 100㎕를 가지고 검액과 같은 방법으로 조작하여 얻은 액을 공시험액으로 하여 그 흡광도 A를 측정하며, 효소액 및 시료 대신 정제수 120㎕를 넣어 검액과 같은 방법으로 조작하여 얻은 액을 색보정액으로 하여 그 흡광도 D를 측정하고, 수학식 1에 따라 엘라스타아제 억제율(%)을 구하였다.Specifically, a substrate solution (elastase substrate Succ-Ala-Ala-Ala-p-nitroanilide standard (SIGMA, S4760) was 8.8 mM) and 20 μl of the sample and 100 μl of the sample (prepared by diluting each sample of Example 1 and Comparative Example 1-2 to a concentration of 100 ppm in purified water) were mixed, and the enzyme solution (10 μg/ml, porcine pancreas) Elastase standard: Porcine Pancreatic Elastase, SIGMA, E-1250) 20 μl) was added, shaken, and reacted at 25° C. for 15 minutes, and the amount of p-nitroaniline produced was measured for absorbance B at a wavelength of 410 nm ( test solution). Absorbance C was measured using the obtained solution as a control solution by putting 20 μl of substrate solution, 20 μl of purified water, and 100 μl of sample into 60 μl of buffer solution. In addition, take 100 μl of purified water instead of the sample and operate in the same way as the sample solution, and measure the absorbance A using the solution obtained as the blank test solution. Using semen, the absorbance D was measured, and the elastase inhibition rate (%) was calculated according to Equation 1.
[수학식 1][Equation 1]
엘라스타아제 저해율(%) = [1 - (시료 처리군의 효소 활성도/대조군의 효소 활성도)] x 100Elastase inhibition rate (%) = [1 - (enzyme activity of sample treatment group/enzyme activity of control group)] x 100
하기 표 1에 엘라스타아제 저해활성을 백분율로 나타내었다.Table 1 below shows the elastase inhibitory activity as a percentage.
(처리농도 100ppm)sample
(treatment concentration 100ppm)
(Oleanolic acid)oleanolic acid
(Oleanolic acid)
(소라 펩타이드:전복 펩타이드, 1:1 중량비 혼합 시료)Example 1
(Sora peptide: abalone peptide, 1:1 weight ratio mixed sample)
(소라 펩타이드)Comparative Example 1
(Sora Peptide)
(전복 펩타이드)Comparative Example 2
(abalone peptide)
상기 표 1에 나타난 바와 같이, 소라 또는 전복 펩타이드 단독 시료 대비 혼합하여 사용한 시료에서 엘라스타아제 저해율이 현저히 높게 나타났다. 따라서, 실시예 1(소라+전복)은 피부 주름개선 효과가 우수함을 확인할 수 있었다.As shown in Table 1, the elastase inhibition rate was significantly higher in the mixed sample compared to the conch or abalone peptide alone sample. Therefore, it was confirmed that Example 1 (conch + abalone) had an excellent skin wrinkle improvement effect.
<실험예 2> 보습력 평가<Experimental Example 2> Moisturizing power evaluation
실험예 1에서 준비한 것과 동일한 실시예 1 및 비교예 1-2의 시료(각 펩타이드 분말을 증류수에 100ppm 농도로 희석함)에 대한, 보습 효과를 코르네오메터 CM 825(Corneometer CM 825, Courate + Khazaka사)를 사용하여 하기와 같이 측정하였으며, 대조구로는 증류수를 사용하였다.The moisturizing effect of the samples of Example 1 and Comparative Example 1-2 (each peptide powder was diluted to 100 ppm concentration in distilled water) as prepared in Experimental Example 1 was measured by Corneometer CM 825 (Corneometer CM 825, Courate + Khazaka). g) was measured as follows, and distilled water was used as a control.
실험 방법은 20대 여성 8명을 대상으로 상박부 2 x 2 ㎠, 8구획 나누어 구분하고, 물로 여러 차례 세정한 후, 자극 없이 수분을 제거하였다. 15분 경과 후, 실시예 1과 비교예 1-2의 시료를 각각 2 구획에 대하여 10㎕씩 점적하여 고르게 도포하였다. 2시간 경과 후, 코르네오메터 CM 825(Corneometer CM 825, Courate + Khazaka 사)를 이용하여 하나의 구획 당 5 회 측정하였다. 실험 실내온도는 21 ± 2℃, 상대습도 50 ± 5%의 항온 항습실에서 실시하였다. 코르네오메터의 탐침을 측정부위 표면에 밀착 접촉 후 가볍게 누르면 나타나는 수치를 임의 단위(arbitrary unit=AU)로 표시하였다. 측정값은 5회 측정하여 얻어진 값을 하기 수학식 2을 이용하여 평균값을 구하여, 대상자 8명의 평균값을 표 2에 나타내었다.For the experimental method, 8 women in their 20s were divided into 2 x 2 cm2, 8 compartments of the upper arm, washed several times with water, and then moisture was removed without irritation. After 15 minutes, the samples of Example 1 and Comparative Example 1-2 were uniformly applied by dropwise 10 μl of each of the 2 compartments. After 2 hours, measurements were taken 5 times per compartment using a Corneometer CM 825 (Courate + Khazaka). The experiment was conducted in a constant temperature and humidity room with a room temperature of 21 ± 2 °C and a relative humidity of 50 ± 5%. The numerical value that appears when the probe of the corneometer is lightly pressed after close contact with the surface of the measurement site is expressed in arbitrary unit (arbitrary unit = AU). The measured value was obtained by measuring 5 times and the average value was obtained using Equation 2 below, and the average value of 8 subjects is shown in Table 2.
[수학식 2][Equation 2]
보습력 (코르네오메터값, Corneometer Value) = △S - SMoisture power (Corneometer Value) = △S - S
S : 시료 도포 전 코르네오메터 값S : Corneometer value before sample application
△S : 시료 도포 2시간 경과 후 코르네오메터 값△S : Corneometer value after 2 hours of sample application
표 2에 나타난 바와 같이, 소라 또는 전복 펩타이드 단독 시료 대비 혼합하여 사용한 시료에서 보습력이 현저히 높게 나타났다. 따라서, 실시예 1(소라+전복)은 피부 보습 효과가 우수함을 확인할 수 있었다.As shown in Table 2, the moisturizing power was significantly higher in the sample mixed with conch or abalone peptide compared to the sample alone. Therefore, it was confirmed that Example 1 (conch + abalone) had an excellent skin moisturizing effect.
화장료의 제조예Preparation example of cosmetics
본 발명에 따른 유효물질은 목적에 따라 여러 형태의 화장료로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 화장료의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be manufactured into various types of cosmetics depending on the purpose. The following exemplifies the manufacturing method of several cosmetics containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.
<화장료 제조예 1> 유연 화장수의 제조<Cosmeceutical Preparation Example 1> Preparation of softened lotion
유효물질 10.0 중량부active substance 10.0 parts by weight
1,3-부틸렌글리콜 1.00 중량부1,3-butylene glycol 1.00 parts by weight
디소듐이디티에이 0.05 중량부Disodium EDIT 0.05 parts by weight
알란토인 0.10 중량부allantoin 0.10 parts by weight
디포타슘글리시리제이트 0.05 중량부Dipotassium glycyrrhizate 0.05 parts by weight
시트르산 0.01 중량부citric acid 0.01 parts by weight
소듐시트레이트 0.02 중량부sodium citrate 0.02 parts by weight
글리세레스-26 1.00 중량부Glyceres-26 1.00 parts by weight
알부틴 2.00 중량부arbutin 2.00 parts by weight
하이드로제네이티드캐스터오일 1.00 중량부Hydrogenated Castor Oil 1.00 parts by weight
에탄올 30.0 중량부ethanol 30.0 parts by weight
보존제 미량preservative a very small amount
착색제 미량coloring agent a very small amount
착향제 미량flavoring agent a very small amount
정제수 잔량Purified water remaining amount
<화장료 제조예 2> 영양 크림의 제조<Cosmeceutical Preparation Example 2> Preparation of nourishing cream
유효물질 10.0 중량부active substance 10.0 parts by weight
1,3-부틸렌글리콜 7.00 중량부1,3-butylene glycol 7.00 parts by weight
글리세린 1.00 중량부glycerin 1.00 parts by weight
D-판테놀 0.10 중량부D-Panthenol 0.10 parts by weight
식물 추출물 3.20 중량부plant extract 3.20 parts by weight
마그네슘알루미늄실리케이트 0.30 중량부Magnesium Aluminum Silicate 0.30 parts by weight
PEG-40 스테아레이트 1.20 중량부PEG-40 Stearate 1.20 parts by weight
스테아르산 2.00 중량부stearic acid 2.00 parts by weight
폴리소르베이트 60 1.50 중량부Polysorbate 60 1.50 parts by weight
친유형글리세릴스테아레이트 2.00 중량부Lipophilic Glyceryl Stearate 2.00 parts by weight
소르비탄세스퀴올리에이트 1.50 중량부Sorbitan sesquioleate 1.50 parts by weight
세테아릴알코올 3.00 중량부cetearyl alcohol 3.00 parts by weight
미네랄오일 4.00 중량부mineral oil 4.00 parts by weight
스쿠알란 3.80 중량부squalane 3.80 parts by weight
카르릴릭/카프릭트리글리세라이드 2.80 중량부Carlylic/Capric Triglycerides 2.80 parts by weight
식물성오일 1.80 중량부vegetable oil 1.80 parts by weight
디메치콘 0.40 중량부dimethicone 0.40 parts by weight
디포슘글리시리제이트 미량dipotassium glycyrrhizate a very small amount
알란토인 미량allantoin a very small amount
소듐 히아루로네이트 미량Sodium Hyaluronate a very small amount
토코페릴아세테이트 적량tocopheryl acetate appropriate amount
트리에탄올아민 적량triethanolamine appropriate amount
보존제 적량preservative appropriate amount
착향제 적량flavoring agent appropriate amount
정제수 잔량Purified water remaining amount
건강식품의 제조예Manufacturing example of health food
본 발명에 따른 유효물질은 목적에 따라 여러 형태의 건강식품으로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 건강식품의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be manufactured into various types of health food depending on the purpose. The following exemplifies the manufacturing method of several health foods containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.
<건강식품 제조예 1> 유제품(dairy products)의 제조<Health food production example 1> Production of dairy products
본 발명의 유효물질 0.01-1 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.0.01-1 parts by weight of the active substance of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
<건강식품 제조예 2> 선식의 제조<Health food production example 2> Preparation of wire
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다. 검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다. 본 발명의 유효물질을 진공 농축기에서 감압농축하고 건조분말을 얻었다. 상기에서 제조한 곡물류, 종실류 및 유효물질의 건조분말을 다음의 비율로 배합하여 제조하였다.Brown rice, barley, glutinous rice, and barley radish were pregelatinized by a known method and dried, and then roasted and prepared as a powder having a particle size of 60 mesh with a grinder. Black soybeans, black sesame, and perilla were also steamed and dried by a known method, and then roasted and prepared into powder having a particle size of 60 mesh with a grinder. The active material of the present invention was concentrated under reduced pressure in a vacuum concentrator to obtain a dry powder. It was prepared by mixing the dry powders of grains, seeds and active substances prepared above in the following ratios.
곡물류(현미 34 중량부, 율무 19 중량부, 보리 20 중량부),Grains (34 parts by weight of brown rice, 19 parts by weight of barley, 20 parts by weight of barley),
종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame),
유효물질 (2 중량부),Active substance (2 parts by weight),
영지(1.5 중량부), 및Reishi (1.5 parts by weight), and
지황(1.5 중량부).Rehmannia (1.5 parts by weight).
건강기능식품의 제조예Manufacturing example of health functional food
본 발명에 따른 유효물질은 목적에 따라 여러 형태의 건강기능식품으로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 건강기능식품의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be manufactured into various types of health functional food depending on the purpose. The following exemplifies the manufacturing method of several health functional foods containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.
<건강기능식품 제조예 1> 건강기능식품의 제조<Health functional food manufacturing example 1> Manufacturing of health functional food
유효물질 100 mgactive substance 100 mg
비타민 혼합물 적량vitamin mixture appropriate amount
비타민 A 아세테이트 70 μgvitamin A acetate 70 μg
비타민 E 1.0 mgvitamin E 1.0 mg
비타민 B1 0.13 mgvitamin B1 0.13 mg
비타민 B2 0.15 mgvitamin B2 0.15 mg
비타민 B6 0.5 mgvitamin B6 0.5 mg
비타민 B12 0.2 μgvitamin B12 0.2 μg
비타민 C 10 mgvitamin C 10 mg
비오틴 10 μgbiotin 10 μg
니코틴산아미드 1.7 mgNicotinamide 1.7 mg
엽산 50 μgfolic acid 50 μg
판토텐산 칼슘 0.5 mgCalcium Pantothenate 0.5 mg
무기질 혼합물 적량mineral mixture appropriate amount
황산제1철 1.75 mgferrous sulfate 1.75 mg
산화아연 0.82 mgzinc oxide 0.82 mg
탄산마그네슘 25.3 mgmagnesium carbonate 25.3 mg
제1인산칼륨 15 mgmonobasic potassium phosphate 15 mg
제2인산칼슘 55 mgdicalcium phosphate 55 mg
구연산칼륨 90 mgpotassium citrate 90 mg
탄산칼슘 100 mgcalcium carbonate 100 mg
염화마그네슘 24.8 mgmagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강기능성 식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강기능성 식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능성 식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the vitamin and mineral mixture is relatively suitable for health functional food in a preferred embodiment, the composition ratio may be arbitrarily modified. Then, the granules can be prepared and used in the production of a health functional food composition according to a conventional method.
<건강기능식품 제조예 2> 건강 기능 음료의 제조<Health functional food production example 2> Preparation of health functional beverage
유효물질 100 mgactive substance 100 mg
구연산 100 mgcitric acid 100 mg
올리고당 100 mgoligosaccharide 100 mg
매실농축액 2 mgPlum Concentrate 2 mg
타우린 100 mgTaurine 100 mg
정제수를 가하여 전체 500 mLPurified water is added to 500 mL
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 1 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. 상기 조성비는 비교적 기호 음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용 용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.After mixing the above ingredients according to a conventional health drink manufacturing method, after stirring and heating at 85° C. for about 1 hour, the resulting solution is filtered and obtained in a sterilized container, sealed and sterilized, and then refrigerated. used in the manufacture of health beverage compositions. Although the composition ratio is prepared by mixing ingredients suitable for relatively favorite beverages in a preferred embodiment, the mixing ratio may be arbitrarily modified according to regional and national preferences such as demand class, demand country, and use purpose.
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특히 청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, with respect to the present invention, the preferred embodiments have been looked at. Those of ordinary skill in the art to which the present invention pertains will understand that the present invention can be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments are to be considered in an illustrative rather than a restrictive sense. The scope of the present invention is particularly indicated in the claims rather than in the foregoing description, and all differences within the scope equivalent thereto should be construed as being included in the present invention.
Claims (16)
A cosmetic composition for skin wrinkle improvement or moisturizing comprising a conch-derived peptide and an abalone-derived peptide.
상기 소라는 제주산 소라(Turbo cornutus Lightfoot)이고,
상기 전복은 제주산 전복(Nordotis discus discus)인 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
According to claim 1,
The conch is Jeju conch ( Turbo cornutus Lightfoot ),
The abalone is Jeju abalone ( Nordotis discus discus ), characterized in that the skin wrinkle improvement or moisturizing cosmetic composition.
상기 소라 유래 펩타이드는,
소라육을 40-80℃에서 12-72시간 건조하는 단계(단계 1);
상기 단계 1의 건조된 소라육을 20-100 mesh로 분쇄하는 단계(단계 2);
상기 단계 2의 소라육 100 중량부에 정제수를 800-1000 중량부로 혼합 후, 1.4-1.6 atm, 100-120℃ 에서 30-40분간 자숙하는 단계(단계 3);
상기 단계 3의 소라육 자숙물 1000 중량부에 가수분해원을 1-10 중량부로 혼합하여 3-24시간 동안, 25-50℃에서 발효 후, 80-90℃에서 10-20분간 효소를 비활성화 하는 단계 (단계 4); 및
상기 단계 4의 발효 후 2,000-6,000rpm으로 원심분리한 후 농축 및 동결건조하여 분말로 제조하는 단계(단계 5);
를 포함하여 제조되는 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
According to claim 1,
The sora-derived peptide is
drying the beef meat at 40-80° C. for 12-72 hours (step 1);
pulverizing the dried beef meat of step 1 to 20-100 mesh (step 2);
After mixing 800-1000 parts by weight of purified water with 100 parts by weight of the beef meat of step 2, self-restraint at 1.4-1.6 atm, 100-120° C. for 30-40 minutes (step 3);
1-10 parts by weight of a hydrolysis source is mixed with 1000 parts by weight of the boiled beef broth of step 3, fermented at 25-50°C for 3-24 hours, and then the enzyme is inactivated at 80-90°C for 10-20 minutes. step (step 4); and
After the fermentation of step 4, centrifugation at 2,000-6,000 rpm, concentration and freeze-drying to prepare a powder (step 5);
A cosmetic composition for wrinkle improvement or moisturizing of the skin, characterized in that it is prepared by including.
상기 전복 유래 펩타이드는,
전복의 패각 및 내장을 제거한 후, 전복육을 40-80℃에서 12-72시간 건조하는 단계(단계 1);
상기 단계 1의 건조된 전복육을 20-100 mesh로 분쇄하는 단계(단계 2);
상기 단계 2의 전복육 분말 100 중량부에 정제수 800-1000 중량부를 혼합 후, 1.4-1.6 atm, 100-120℃에서 30-40분간 자숙하는 단계(단계 3);
상기 단계 3에서 정제수를 버리고 남은 자숙 전복육 100 중량부 기준 1N 농도의 수산화나트륨 800-1000 중량부를 첨가한 후 70-90℃에서 3-5시간 동안 125-175 rpm으로 교반하여 전복육의 단백질을 추출하는 단계(단계 4);
상기 단계 4에서 얻은 전복육 단백질 추출물을 교반하며 아세트산을 첨가하여 pH 2-4로 조절한 다음, 3000-4000 rpm에서 5-15분간 원심분리하여 침전물을 얻는 단계(단계 5);
상기 단계 5에서 얻은 침전물을 교반하며 1N 농도의 수산화나트륨을 첨가하여 pH 6.5-7.5까지 중화시키는 단계(단계 6); 및
상기 단계 6에서 얻은 중화된 침전물에 에탄올을 첨가하여 세척한 다음 에탄올을 제거하여, 전복 펩타이드를 얻는 단계(단계 7);
를 포함하여 제조되는 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
According to claim 1,
The abalone-derived peptide is
After removing the shell and intestines of abalone, drying the abalone meat at 40-80° C. for 12-72 hours (step 1);
pulverizing the dried abalone meat of step 1 to 20-100 mesh (step 2);
After mixing 800-1000 parts by weight of purified water with 100 parts by weight of the abalone meat powder of step 2 above, 1.4-1.6 atm, 100-120° C. for 30-40 minutes (step 3);
After discarding the purified water in step 3 and adding 800-1000 parts by weight of sodium hydroxide at a 1N concentration based on 100 parts by weight of the remaining raw abalone meat, the protein of the abalone meat was prepared by stirring at 125-175 rpm at 70-90° C. for 3-5 hours. extracting (step 4);
The abalone protein extract obtained in step 4 is stirred and adjusted to pH 2-4 by adding acetic acid, and then centrifuged at 3000-4000 rpm for 5-15 minutes to obtain a precipitate (step 5);
neutralizing the precipitate obtained in step 5 to pH 6.5-7.5 by adding 1N sodium hydroxide while stirring (step 6); and
Washing by adding ethanol to the neutralized precipitate obtained in step 6, then removing the ethanol to obtain an abalone peptide (step 7);
A cosmetic composition for wrinkle improvement or moisturizing of the skin, characterized in that it is prepared by including.
상기 단계 3은 105-115℃에서 32-38분간 자숙하는 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
4. The method of claim 3,
The step 3 is a cosmetic composition for improving wrinkles or moisturizing the skin, characterized in that it is self-retained at 105-115° C. for 32-38 minutes.
상기 단계 4의 가수분해원은 프로테아제(protease) 또는 펩티다아제(peptidase)를 포함하는 미생물 또는 단백질 가수분해 효소인 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
4. The method of claim 3,
The hydrolysis source of step 4 is a microorganism or proteolytic enzyme containing protease or peptidase, a cosmetic composition for improving wrinkles or moisturizing the skin.
상기 프로테아제(protease) 또는 펩티다아제(peptidase)를 포함하는 미생물은 바실러스 서브틸러스(bacillus subtilis)인 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
7. The method of claim 6,
The microorganism containing the protease (protease) or peptidase (peptidase) is Bacillus subtilis (bacillus subtilis), characterized in that the skin wrinkle improvement or moisturizing cosmetic composition.
상기 단백질 가수분해 효소는 메탈로펩티다아제 및 메탈로프로테아제로 이루어진 군으로부터 선택된 1종 이상인 것을 특징으로 하는 제조방법.
7. The method of claim 6,
The proteolytic enzyme is a production method, characterized in that at least one selected from the group consisting of metallopeptidase and metalloprotease.
상기 단백질 가수분해 효소는 썰모라이신(Thermolysin)인 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
9. The method of claim 8,
The proteolytic enzyme is thermolysin (Thermolysin), characterized in that the skin wrinkle improvement or moisturizing cosmetic composition.
크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크 로션, 모이스처 로션, 영양로션, 마사지 크림, 영양크림, 모이스처 크림, 핸드 크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어진 군에서 선택되는 어느 하나의 제형으로 제조된 것을 특징으로 하는, 피부의 주름개선 또는 보습용 화장료 조성물.
According to claim 1,
Cream, softening lotion, nourishing lotion, pack, essence, hair tonic, shampoo, conditioner, hair conditioner, hair treatment, gel, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, Massage cream, nourishing cream, moisture cream, hand cream, foundation, nourishing essence, sunscreen, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser. A cosmetic composition for wrinkle improvement or moisturizing of the skin, characterized in that.
A health food composition for preventing or improving skin wrinkles, comprising a conch-derived peptide and an abalone-derived peptide.
상기 건강식품 조성물은 이너뷰티(inner beauty) 식품인 것을 특징으로 하는 피부 주름 예방 또는 개선용 건강식품 조성물.
12. The method of claim 11,
The health food composition is a health food composition for preventing or improving skin wrinkles, characterized in that it is an inner beauty food.
상기 건강식품 조성물은 젤리 형태인 것을 특징으로 하는 피부 주름 예방 또는 개선용 건강식품 조성물.
12. The method of claim 11,
The health food composition is a health food composition for preventing or improving skin wrinkles, characterized in that it is in the form of a jelly.
A health functional food composition for preventing or improving skin wrinkles, comprising a conch-derived peptide and an abalone-derived peptide.
상기 건강기능식품 조성물은 이너뷰티(inner beauty) 식품인 것을 특징으로 하는 피부 주름 예방 또는 개선용 건강기능식품 조성물.
15. The method of claim 14,
The health functional food composition is a health functional food composition for preventing or improving skin wrinkles, characterized in that it is an inner beauty food.
상기 건강기능식품 조성물은 젤리 형태인 것을 특징으로 하는 피부 주름 예방 또는 개선용 건강기능식품 조성물.15. The method of claim 14,
The health functional food composition is a health functional food composition for preventing or improving skin wrinkles, characterized in that it is in the form of a jelly.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200139649 | 2020-10-26 | ||
KR1020200139649 | 2020-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220055431A true KR20220055431A (en) | 2022-05-03 |
Family
ID=81590948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210142547A KR20220055431A (en) | 2020-10-26 | 2021-10-25 | Composition for anti-wrinkle or moisturizing containing Turbo cornutus Lightfoot and Nordotis discus discus derived peptide |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220055431A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170016408A (en) | 2017-01-26 | 2017-02-13 | 경기도 | A Cosmetic Composition for Whitening or Pore-Minimizing Comprising Extract of cone scale of Pinus koraiensis Siebold et Zucc |
-
2021
- 2021-10-25 KR KR1020210142547A patent/KR20220055431A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170016408A (en) | 2017-01-26 | 2017-02-13 | 경기도 | A Cosmetic Composition for Whitening or Pore-Minimizing Comprising Extract of cone scale of Pinus koraiensis Siebold et Zucc |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016047907A1 (en) | Composition, containing tyndallized lactobacillus dead cells as active ingredient, for skin moisturizing or wrinkle improvement | |
KR101685581B1 (en) | Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom | |
CN110249055B (en) | Fermented product and method for producing same | |
JP2008201773A (en) | External preparation for skin | |
KR20140016461A (en) | Fermented sea cucumber extract and its cosmetic usage | |
KR101336804B1 (en) | Fermented ear shell using mushroom, manufacturing method thereof and cosmetic composition comprising the same | |
KR101742542B1 (en) | Composition for moisturizing skin and anti-wrinkle comprising tyndalized lactic acid bacteria as effective component | |
KR101437997B1 (en) | Fermented caviar extract and its cosmetic usage | |
KR101875188B1 (en) | Functional cosmetic composition comprising tengcha | |
KR101804793B1 (en) | Process for producing red sea cucumber-derived peptide powder and cosmetic composition for anti-wrinkle containing the same | |
KR102365655B1 (en) | Composition for preventing or improving skin wrinkle containing Glycine max Merrill fermented extract | |
KR102376607B1 (en) | Inner beauty composition for anti-wrinkle and moisturizing containing red sea cucumber and abalone derived peptide, and ginseng extracts | |
KR102077708B1 (en) | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component | |
KR20200083293A (en) | Cosmetic composition comprising mixture of fermented extract of Cirsium japonicum and Moringa oleifera | |
KR102016909B1 (en) | Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder | |
KR20140068679A (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
KR20200074361A (en) | Composition for skin whitening and composition for ultraviolet-proof comprising the extract of fermented Astragalus membranaceus Bunge | |
KR102290291B1 (en) | Composition for improving moisturizing skin containing fermented blueberry and black rice extracts | |
KR102449136B1 (en) | Compositions containing Taraxacum coreanum extract | |
KR20220055431A (en) | Composition for anti-wrinkle or moisturizing containing Turbo cornutus Lightfoot and Nordotis discus discus derived peptide | |
KR102117761B1 (en) | Red sea cucumber-derived low salt peptide powder and process for producing the same | |
KR101834153B1 (en) | Process for producing red sea cucumber-derived peptide powder and cosmetic composition for skin whitening containing the same | |
KR102520908B1 (en) | Preparation of aged solution of fruit of dioscorea opposita thumb, and aged solution of fruit of dioscorea opposita thumb prepared thereby | |
KR102481095B1 (en) | Inner beauty composition for anti-wrinkle containing red sea cucumber and fish collagen | |
KR102525129B1 (en) | Composition comprising fermented extracts of unripe plum and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |